In xenograft mice models of PIK3CA mutant breast cancer and PTEN-deficient prostate cancer, the excessive activation of the PI3K-AKT-mTOR signaling protects cancer cells from LPO and ferroptosis by SREBP1/SCD1-mediated MUFA synthesis [69]. Here, PTEN is linked to prostate carcinoma.